Nov. 18th, 2009

ymarkov: (Default)
James Taranto blogs at WSJ:
One of the advantages of a market-based medical system is that countervailing interests keep one another honest. Sure, the insurance companies want to cut costs, but providers of medical goods and services have incentives that militate in the opposite direction--and, one hopes, disinterested government regulators keep everyone honest. In a socialized health-care system, by contrast, the government is all those special interests, and you can forget about counting on it to keep itself honest.

Speaking of which, check out this report in the Los Angeles Times:

Congressional Democrats' intensifying efforts to pay for their healthcare overhaul and provide more relief for consumers are threatening to unravel a White House deal with the pharmaceutical industry and turn one of Washington's most powerful lobbies against the legislation. Drug makers, which have already spent $110 million lobbying Congress this year, are preparing to make a stand in the Senate, where Majority Leader Harry Reid (D-Nev.) is working to unveil a healthcare bill this week. And senior administration officials, including White House Chief of Staff Rahm Emanuel, are warning members of Congress not to antagonize the deep-pocketed industry at a time when a major victory appears to be within reach, according to Democratic aides.

Do you trust your health to the Obama administration? To the drug companies? If you answered "yes" to both these questions, you're even crazier than if you answered "yes" to one of them.

Profile

ymarkov: (Default)
Yisroel Markov

December 2025

S M T W T F S
 12 3456
78910111213
14151617181920
21222324252627
28293031   

Most Popular Tags

Style Credit

Expand Cut Tags

No cut tags
Page generated Dec. 20th, 2025 03:27 am
Powered by Dreamwidth Studios